NCT03717272View on ClinicalTrials.gov

Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

January 1, 2021

Conditions
Marijuana Abuse
Interventions
DRUG

AEF0117

AEF0117 capsules

DRUG

Placebo oral capsule

Corn oil capsule manufactured to mimic AEF0117 capsule

Trial Locations (1)

10032

Substance Use Research Center, New York

Sponsors

Lead Sponsor

Aelis Farma
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Columbia University

OTHER

collaborator

New York State Psychiatric Institute

OTHER

collaborator

ClinStar, LLC

INDUSTRY

lead

Aelis Farma

INDUSTRY

NCT03717272 - Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects | Biotech Hunter | Biotech Hunter